← Open Payments lookup

ROBERT LEETH: Open Payments

NPI 1881657237 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,002 in 88 payments from 15 companies in 2025. Trend: 2023 $139 · 2024 $806 · 2025 $3,002

Food & beverage: $2,219Travel & lodging: $783
CompanyPaymentsAmount
Neuronetics, Inc.3$1,126
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$489
Janssen Pharmaceuticals, Inc6$314
Otsuka America Pharmaceutical, Inc.12$195
Teva Pharmaceuticals USA, Inc.7$181
Lundbeck LLC6$129
Axsome Therapeutics, Inc.8$110
Alkermes, Inc.5$105
Supernus Pharmaceuticals, Inc.2$80
Neurocrine BioSciences, Inc.3$68

Products named: NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA, INVEGA SUSTENNA, REXULTI, AUSTEDO XR, LYBALVI, Qelbree, UZEDY.

Industry payments across ID — which companies pay providers there.